Literature DB >> 26498471

Molecular characterization of BK virus in patients infected with human immunodeficiency virus.

Danijela Karalic1, Ivana Lazarevic2, Ana Banko2, Maja Cupic2, Djordje Jevtovic3, Tanja Jovanovic2.   

Abstract

Immunosuppression seems to be the most important cause of BKPyV reactivation. Recently, a spectrum of diseases associated with BKPyV infection has been reported in HIV-infected patients. BKPyV isolates can be classified into four subtypes based on nucleotide polymorphisms within VP1 coding region. Mutations within the BC loop of the VP1 may be associated with an increase in the viral pathogenicity. The aims of this study were to determine prevalence and distribution of BKPyV subtypes, sequence variation and mutations within VP1 among HIV-infected patients and healthy donors. Urine samples from 114 HIV-infected patients and 120 healthy donors were collected. PCR followed by sequence analysis was carried out using primers specific for VP1 and NCRR of the virus genome. The predominant BKPyV subtype was I, followed by IV. In isolates from HIV-infected patients, the majority of non-synonymous alterations were located within the BC loop. BKV sequences from healthy donors showed non-synonymous alterations outside of the receptor loops in the β-sheets. The higher frequency of mutations in the BC loop of VP1 protein was detected among HIV-infected patients. The most frequent mutation was E82D. All HIV-infected patients who harbored mutations had CD4(+) cell counts less than 200 cell/mm(3). It seems that immunosuppression is a very important factor for BKPyV reactivation that can increase viral replication rate and leads to higher frequency of mutations in the BC loop of the VP1. These mutations may change receptor specificity, and further studies are needed to determine the effect of these mutations on the biological properties of the BKPyV.

Entities:  

Keywords:  BC loop; BK virus; HIV; Mutation; Subtype; VP1

Mesh:

Substances:

Year:  2015        PMID: 26498471     DOI: 10.1007/s00430-015-0439-5

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  42 in total

Review 1.  Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV).

Authors:  Wendy A Knowles
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

2.  Identification of a neutralization epitope in the VP1 capsid protein of SV40.

Authors:  Haruhiko Murata; Belete Teferedegne; Li Sheng; Andrew M Lewis; Keith Peden
Journal:  Virology       Date:  2008-09-11       Impact factor: 3.616

3.  BK virus as cause of haemorrhagic cystitis after bone marrow transplantation.

Authors:  S J Rice; J A Bishop; J Apperley; S D Gardner
Journal:  Lancet       Date:  1985-10-12       Impact factor: 79.321

4.  Subtype IV of the BK polyomavirus is prevalent in East Asia.

Authors:  Q Chen; H-Y Zheng; S Zhong; H Ikegaya; H-X He; W Wei; Y-Y He; N Kobayashi; T Honjo; T Takasaka; S Takahashi; T Kitamura; Y Yogo
Journal:  Arch Virol       Date:  2006-07-10       Impact factor: 2.574

5.  Genetic and structural analysis of a virulence determinant in polyomavirus VP1.

Authors:  P H Bauer; R T Bronson; S C Fung; R Freund; T Stehle; S C Harrison; T L Benjamin
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

6.  Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008.

Authors:  Eileen Schneider; Suzanne Whitmore; Kathleen M Glynn; Kenneth Dominguez; Andrew Mitsch; Matthew T McKenna
Journal:  MMWR Recomm Rep       Date:  2008-12-05

7.  BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions.

Authors:  A Sundsfjord; T Flaegstad; R Flø; A R Spein; M Pedersen; H Permin; J Julsrud; T Traavik
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

8.  Role of JC virus agnoprotein in DNA repair.

Authors:  Armine Darbinyan; Khwaja M Siddiqui; Dorota Slonina; Nune Darbinian; Shohreh Amini; Martyn K White; Kamel Khalili
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  BK virus antigenic variants: sequence analysis within the capsid VP1 epitope.

Authors:  L Jin; P E Gibson; W A Knowles; J P Clewley
Journal:  J Med Virol       Date:  1993-01       Impact factor: 2.327

10.  A structure-guided mutation in the major capsid protein retargets BK polyomavirus.

Authors:  Ursula Neu; Stacy-Ann A Allen; Bärbel S Blaum; Yan Liu; Martin Frank; Angelina S Palma; Luisa J Ströh; Ten Feizi; Thomas Peters; Walter J Atwood; Thilo Stehle
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

View more
  4 in total

Review 1.  BK polyomavirus diversity-Why viral variation matters.

Authors:  Jason T Blackard; Stella M Davies; Benjamin L Laskin
Journal:  Rev Med Virol       Date:  2020-03-03       Impact factor: 6.989

2.  The prevalence and isolated subtypes of BK polyomavirus reactivation among patients infected with human immunodeficiency virus-1 in southeastern China.

Authors:  Caiqin Hu; Ying Huang; Juwei Su; Mengyan Wang; Qihui Zhou; Biao Zhu
Journal:  Arch Virol       Date:  2018-02-12       Impact factor: 2.574

3.  Molecular Epidemiology and Variation of the BK Polyomavirus in the Population of Central and Eastern Europe Based on the Example of Poland.

Authors:  Jacek Furmaga; Marek Kowalczyk; Olga Furmaga; Christos A Rokos; Tomasz Zapolski; Leszek Krakowski; Andrzej Jakubczak; Sławomir Rudzki
Journal:  Viruses       Date:  2022-01-21       Impact factor: 5.048

Review 4.  BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection.

Authors:  Darlene Vigil; Nikifor K Konstantinov; Marc Barry; Antonia M Harford; Karen S Servilla; Young Ho Kim; Yijuan Sun; Kavitha Ganta; Antonios H Tzamaloukas
Journal:  World J Transplant       Date:  2016-09-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.